Insider Trades - GILMAN ALFRED G

EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search

GILMAN ALFRED G: Declared Holdings
Company/Relationship	Reported	Shares	Ownership
Eli Lilly and Company Common St Director NYSE:LLY (historical quotes, profile, SEC, other insiders)	30-Nov-12	43,808	Direct
Regeneron Pharmaceuticals, Inc. Director NasdaqGS:REGN (historical quotes, profile, SEC, other insiders)	6-May-13	0	Direct

Insider & restricted shareholder transactions reported over the last two years
Date Shares Stock Transaction
6-May-13 30,000 REGN Option Exercise at $19.69 - $23.84 per share.
(Cost of about $653,000)
6-May-13 30,000 REGN Sale at $260.41 - $264.82 per share.
(Proceeds of about $7,878,000)
30-Nov-12 3,083 LLY Acquisition (Non Open Market) at $47.03 per share.
(Value of $144,993)
7-Aug-12 15,000 REGN Option Exercise at $15.80 per share.
(Cost of $237,000)
7-Aug-12 15,000 REGN Sale at $139.56 per share.
(Proceeds of $2,093,400)
15-Feb-12 26,734 REGN Sale at $109.56 per share.
(Proceeds of $2,928,977)
14-Feb-12 3,266 REGN Disposition (Non Open Market) at $111.01 per share.
(Value of $362,558)
14-Feb-12 30,000 REGN Option Exercise at $9.17 - $15.01 per share.
13-Dec-11 11,875 REGN Disposition (Non Open Market) at $0 per share.
30-Nov-11 3,990 LLY Acquisition (Non Open Market) at $36.34 per share.
(Value of $144,996)

EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search

Copyright © 2013 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Data and information are provided by EDGAR Online, Inc. for informational purposes only and not intended for trading purposes. Yahoo!, EDGAR Online, Inc. shall have no liability for the accuracy of the information furnished or for delays, omissions or opinions expressed therein. You may not use the information for any illegal purpose or furnish the information to any person, firm, or branch office for commercial re-use or re-sale.
Questions or Comments?

Insider & restricted shareholder transactions reported over the last two years
Date	Shares	Stock	Transaction
6-May-13	30,000	REGN	Option Exercise at $19.69 - $23.84 per share. (Cost of about $653,000)
6-May-13	30,000	REGN	Sale at $260.41 - $264.82 per share. (Proceeds of about $7,878,000)
30-Nov-12	3,083	LLY	Acquisition (Non Open Market) at $47.03 per share. (Value of $144,993)
7-Aug-12	15,000	REGN	Option Exercise at $15.80 per share. (Cost of $237,000)
7-Aug-12	15,000	REGN	Sale at $139.56 per share. (Proceeds of $2,093,400)
15-Feb-12	26,734	REGN	Sale at $109.56 per share. (Proceeds of $2,928,977)
14-Feb-12	3,266	REGN	Disposition (Non Open Market) at $111.01 per share. (Value of $362,558)
14-Feb-12	30,000	REGN	Option Exercise at $9.17 - $15.01 per share.
13-Dec-11	11,875	REGN	Disposition (Non Open Market) at $0 per share.
30-Nov-11	3,990	LLY	Acquisition (Non Open Market) at $36.34 per share. (Value of $144,996)